Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier.
Delta sleep-inducing peptide (DSIP) significantly increases delta wave electrical activity in the brain of rats after intraperitoneal (i.p.) injection. Rats (n = 10) were peripherally injected with DSIP and [D-Ala4]DSIP-NH2 during the dark portion of a 12-h light/dark cycle prior to recording of epidural encephalographic (EEG) wave forms. Administration of [D-Ala4]DSIP-NH2, an analog that enters the brain after peripheral administration more readily than the parent DSIP molecule, resulted in significantly more delta waves than DSIP together with a highly significant amount of theta activity. DSIP was found to significantly increase EEG output in the delta range when compared with controls. In addition, the DSIP analog significantly decreased locomotor activity, whereas DSIP itself was without effect. These findings strongly support the controversial concepts that peripherally injected peptides can reach the brain and that DSIP compounds can increase sleep activity.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D003700:Delta Rhythm; D003701:Delta Sleep-Inducing Peptide / Q000031:analogs & derivatives; D004569:Electroencephalography; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats; D012894:Sleep Stages / Q000187:drug effects*
D009842:Oligopeptides; C041971:delta-sleep-inducing peptide amine, Ala(4)-; D003701:Delta Sleep-Inducing Peptide